Editas Medicine (EDIT) Treasury Shares (2015 - 2025)
Editas Medicine (EDIT) reported Treasury Shares of $595730.0 for Q4 2025, down 74.39% year-over-year from $2.3 million in Q4 2024, and down 8.67% on a QoQ basis from $652267.0 in Q3 2025.
Editas Medicine (EDIT) has 11 years of Treasury Shares data on file, last reported at $595730.0 in Q4 2025.
- Quarterly Treasury Shares fell 74.39% year-over-year to $595730.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $595730.0 (down 74.39% YoY) and the FY2025 annual result came in at $595730.0, down 74.39% from the prior year.
- Treasury Shares slipped to $595730.0 in Q4 2025 per EDIT's latest filing, from $652267.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $2.7 million in Q1 2024 and bottomed at $595730.0 in Q4 2025.
- The 5-year median for Treasury Shares is $1.5 million (2022), against an average of $1.5 million.
- The widest annual swing landed in 2022, when Treasury Shares soared 138.43%; it then sank 74.39% in 2025.
- Tracing EDIT's Treasury Shares over 5 years: stood at $628732.0 in 2021, then soared by 138.43% to $1.5 million in 2022, then jumped by 40.56% to $2.1 million in 2023, then rose by 10.41% to $2.3 million in 2024, then slumped by 74.39% to $595730.0 in 2025.
- Per Business Quant, the three latest EDIT Treasury Shares figures stand at $595730.0 (Q4 2025), $652267.0 (Q3 2025), and $923539.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | 595,730.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 595,730.00 |
| Dec 31, 2025 | 595,730.00 |
| Sep 30, 2025 | 652,267.00 |
| Sep 30, 2025 | 652,267.00 |
| Jun 30, 2025 | 923,539.00 |
| Jun 30, 2025 | 923,539.00 |
| Mar 31, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 2.33 Mn |
| Dec 31, 2024 | 2.33 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 2.62 Mn |
| Jun 30, 2024 | 2.62 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 2.11 Mn |
| Dec 31, 2023 | 2.11 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Dec 31, 2021 | 628,732.00 |
| Dec 31, 2021 | 628,732.00 |
| Sep 30, 2021 | 750,456.00 |
| Sep 30, 2021 | 750,456.00 |
| Jun 30, 2021 | 860,596.00 |
| Jun 30, 2021 | 860,596.00 |
| Mar 31, 2021 | 798,034.00 |
| Mar 31, 2021 | 798,034.00 |
| Dec 31, 2020 | 507,450.00 |
| Dec 31, 2020 | 507,450.00 |
| Sep 30, 2020 | 509,878.00 |
| Sep 30, 2020 | 509,878.00 |
| Jun 30, 2020 | 516,131.00 |
| Jun 30, 2020 | 516,131.00 |
| Mar 31, 2020 | 565,828.00 |
| Mar 31, 2020 | 565,828.00 |
| Dec 31, 2019 | 581,408.00 |
| Dec 31, 2019 | 581,408.00 |
| Sep 30, 2019 | 586,892.00 |
| Sep 30, 2019 | 586,892.00 |
| Jun 30, 2019 | 591,473.00 |
| Jun 30, 2019 | 591,473.00 |
| Mar 31, 2019 | 638,054.00 |
| Mar 31, 2019 | 638,054.00 |
| Dec 31, 2018 | 270,000.00 |
| Dec 31, 2018 | 270,000.00 |
| Sep 30, 2018 | 288,000.00 |
| Sep 30, 2018 | 288,000.00 |
| Jun 30, 2018 | 306,000.00 |
| Jun 30, 2018 | 306,000.00 |
| Mar 31, 2018 | 409,200.00 |
| Mar 31, 2018 | 409,200.00 |
| Dec 31, 2017 | 513,225.00 |
| Dec 31, 2017 | 513,225.00 |
| Sep 30, 2017 | 260,784.00 |
| Sep 30, 2017 | 260,784.00 |
| Jun 30, 2017 | 428,153.00 |
| Jun 30, 2017 | 428,153.00 |
| Mar 31, 2017 | 614,345.00 |
| Mar 31, 2017 | 614,345.00 |
| Dec 31, 2016 | 822,638.00 |
| Dec 31, 2016 | 822,638.00 |
| Sep 30, 2016 | 1.02 Mn |
| Sep 30, 2016 | 1.02 Mn |
| Jun 30, 2016 | 1.21 Mn |
| Jun 30, 2016 | 1.21 Mn |
| Mar 31, 2016 | 1.40 Mn |
| Mar 31, 2016 | 1.40 Mn |
| Dec 31, 2015 | 1.60 Mn |
| Dec 31, 2015 | 1.60 Mn |